Digital PCR 'Hits Its Stride'
Submitted by Theral Timpson on Fri, 11/30/2012 - 08:38Podcast brought to you by: Chempetitive Group - Who for more than a decade has helped science-based companies build and execute innovative marketing campaigns. "We love science. We love marketing. We love the idea of combining the two to make great things happen for your marketing communications."
Guests:
George Karlin-Neumann, PhD, Director of Scientific Affairs" for Bio-Rad's Digital Biology Center Bio and Contact Info
Listen (5:00) Understanding Digital PCR
Listen (4:41) Advantages
Listen (1:40) Applications
Listen (3:40) Still room for Real Time PCR
Listen (3:14) First ever dPCR conference
Hanlee Ji, MD, Medical Oncologist, Hematologist / Oncologist in Stanford Bio and Contact Info
Listen (5:09) How is an oncologist using dPCR?
Listen (4:56) A physicians take on personalized medicine
Listen (5:32) Digital technologies already adopted in clinic and dramatically changing war on cancer
In May of this year Nature Methods published an article, “Digital PCR hits its stride.” What is this new technology? Will it replace more conventional methods such as Real Time PCR? And what new opportunities does this new disruptive technology open up?
To answer these questions, we’re joined by George Karlin-Neumann, Director of Scientific Affairs at Bio-Rad’s Digital Center and Hanlee Ji, a physician scientist at Stanford. George explains the exciting new technology and its advantages over Real Time PCR. Hanlee talks about the adoption of the technology in the clinic for the treatment of cancer.
